Hidekatsu Yanai
11PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Dec 07, 2025
The association between thyroid hormone levels and psychiatric symptoms in patients with mania or depression.Mariko Hakoshima, Sarina Tanida, Hisayuki Katsuyama
|Jan 08, 2025
Pathology and Treatments of Alzheimer's Disease Based on Considering Changes in Brain Energy Metabolism Due to Type 2 Diabetes.Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima
|Aug 29, 2024
Retrospective Longitudinal Observational Study on the Long-Term Effects of Sodium-Glucose Cotransporter-2 Inhibitors on the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetic Japanese Patients.Hisayuki Katsuyama, Seiichi Horinaka, Mariko Hakoshima
|Aug 29, 2024
The Significance of Endothelial Dysfunction in Long COVID-19 for the Possible Future Pandemic of Chronic Kidney Disease and Cardiovascular Disease.Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima
|May 25, 2024
Effects of Once-Weekly Semaglutide on Cardiovascular Risk Factors and Metabolic Dysfunction-Associated Steatotic Liver Disease in Japanese Patients with Type 2 Diabetes: A Retrospective Longitudinal Study Based on Real-World Data.Hisayuki Katsuyama, Mariko Hakoshima, Emika Kaji
|Mar 13, 2024
A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease.Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima
Pageof 2
